Maryam Oskoui

NMD4C investigator Dr Maryam Oskoui profile picture

Investigator

Pediatric Neurologist, Neurophysiologist and Epidemiologist, Montreal Children’s Hospital

Professor, Departments of Pediatrics and Neurology and Neurosurgery, McGill University | Scientist, Research Institute of the McGill University Health Centre


NMD4C Involvement: Pillar 2: Clinical Research

Email Maryam

Biography

Dr. Maryam Oskoui is a pediatric neurologist, neurophysiologist and epidemiologist. She is a Distinguished Clinical Research Scholar of the Fonds de Recherche Quebec with a focus in clinical research and clinical trials in pediatric neuromuscular disorders and has contributed to over 100 peer reviewed publications. She is a Principal investigator and SMA lead for INFORM RARE, a Strategy for Patient Oriented Research innovative clinical trial initiative supported by CIHR. 

 

Dr. Oskoui serves as an evidence-based methodologist for the American Academy of Neurology and has contributed to numerous clinical care guidelines. She contributes to the Canadian Neuromuscular community by serving as a member of the Scientific Advisory Committee for Muscular Dystrophy Canada and is past chair of the Canadian Pediatric Neuromuscular Group and the Canadian Neuromuscular Disease Registry’s Spinal Muscular Atrophy Working Group. She is a Board member for the Association des Neurologues du Quebec 

 

Dr. Oskoui completed her medical school and pediatric neurology residency at McGill University (Montreal, Canada), neuromuscular clinical and research fellowship at Columbia University (New York, USA) and Master’s of Science in Clinical Epidemiology at McGill University. 


Recent Publications

Iraqi, I, Ng, P, Chen, X, Cushen, N, Gottowik, J, Herzig, D et al.. Feasibility of a Home-Based Exergaming Intervention for Youth With Spinal Muscular Atrophy. Muscle Nerve. 2025. PMID:40990108

D'Amours, V, Husein, N, Dunbar, M, Fehlings, D, Mishaal, R, Shevell, M et al.. Clinical Phenotype, Predictors and Early Biomarkers of Dyskinetic Cerebral Palsy Prognosis. Pediatr Neurol. 2025.172 101-108 PMID:40913867

Pace, A, Roda, W, Poon, C, McMillan, HJ, Oskoui, M, MacKenzie, A et al.. A cost-utility analysis of newborn screening for spinal muscular atrophy in Canada. Orphanet J Rare Dis. 2025.20 (1)428 PMID:40804727

Oskoui, M, Caller, TA, Parsons, J, Servais, L, Butterfield, RJ, Bharadwaj, J et al.. Delandistrogene Moxeparvovec Gene Therapy in Individuals With Duchenne Muscular Dystrophy: Evidence in Focus: Report of the AAN Guidelines Subcommittee. Neurology. 2025.105 (4)e214014 PMID:40737572

Keezer, MR, Oskoui, M, Pack, AM. Author Response: Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM. Neurology. 2025.105 (3)e210186 PMID:40638883

See more on PubMed